Researchers from Aston University and Birmingham Children’s Hospital have developed a new medication regimen that could successfully treat a bacterial infection that could prove fatal to patients with ...

A new treatment developed by researchers at Aston University and Birmingham Children's Hospital has been found to completely kill a bacterial infection that can be deadly to cystic fibrosis patients A ...

Jan. 23, 2013 — New research suggests that lowering excessive levels of a protein in immune system cells could be a strategy to clear an infection that is deadly to patients with cystic fibrosis (CF).

Cystic fibrosis (CF) affects over 100,000 people worldwide and is caused by one of several known mutations in the CFTR (cystic fibrosis transmembrane conductance regulator) gene. The CFTR protein is a ...

Researchers have shown for the first time how bacteria can grow directly in the lungs of cystic fibrosis patients, giving them the opportunity to get tremendous insights into bacteria behavior and ...

The U.S. Food and Drug Administration today approved TOBI Podhaler (tobramycin inhalation powder) for the management of cystic fibrosis patients with Pseudomonas aeruginosa, a bacterium that causes ...

Cells sent to fight infections in the lungs of cystic fibrosis patients actually enhance the development of permanent bacterial infections, according to researchers at National Jewish Medical and ...

Using a virus to kill a bacterium may seem like going backward in medicine and harkens back to the early 20 th century when Julius Wagner-Juarreg used malaria to cure neurosyphilis (a feat that won ...

Please provide your email address to receive an email when new articles are posted on . In a recent study, researchers in the Netherlands found that hepatic cyst infection recurrence was common and ...

Cystic fibrosis pulmonary disease is characterized by chronic and recurrent infection, airway inflammation, bronchiectasis and progressive obstructive lung physiology. Advances in the treatment of ...